Table 3.

Relative risks (RR) for variables related to catheter-associated SBP and adverse eventsⁱ.

Variable	Catheter-associated SBP‡		Adverse events
	RR	95% CI†	RR	95% CI
Age ≥ 65 years	1.4	0.54, 3.42	0.9	0.49, 1.83
Male gender	0.9	0.33, 2.14	1.2	0.62, 2.40
Cardiovascular disease	1.8	0.70, 4.36	1.4	0.74, 2.52
Chronic kidney disease	1.0	0.36, 2.90	1.2	0.54, 2.57
ECOG! ≥ 3	1.6	0.27, 9.33	1.2	0.41, 3.24
Hyponatremia¥	2.0	0.65, 6.26	1.2	0.62, 2.34
Ascitic protein > 10 g/L	1.8	0.31, 10.55	1.3	0.47, 3.63
MELD§≥ 15	0.3•	0.09, 0.84	0.6	0.34, 1.14
Child-Pugh class B	6.5	0.96, 43.72	2.0	0.86, 4.57

ⁱAdverse events included catheter obstruction or displacement, infections, prerenal azotemia, hematoma, or ascites outflow around the catheter site.

^‡SBP, spontaneous bacterial peritonitis.

^†CI, confidence interval.

^!Eastern cooperative oncology group performance status score.

^¥Serum sodium < 135 mmol/L.

^§Model for end-stage liver disease score.

^• p value ≤ 0.05.